France Hemodynamic Monitoring Devices Market Size & Outlook
Related Markets
France hemodynamic monitoring devices market highlights
- The France hemodynamic monitoring devices market generated a revenue of USD 62.4 million in 2024 and is expected to reach USD 110.2 million by 2033.
- The France market is expected to grow at a CAGR of 6.6% from 2025 to 2033.
- In terms of segment, monitors was the largest revenue generating product in 2024.
- Disposables is the most lucrative product segment registering the fastest growth during the forecast period.
Hemodynamic monitoring devices market data book summary
| Market revenue in 2024 | USD 62.4 million |
| Market revenue in 2033 | USD 110.2 million |
| Growth rate | 6.6% (CAGR from 2025 to 2033) |
| Largest segment | Monitors |
| Fastest growing segment | Disposables |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monitors, Disposables |
| Key market players worldwide | Edwards Lifesciences Corp, GE HealthCare Technologies Inc Common Stock, Baxter International Inc, ICU Medical Inc, Koninklijke Philips NV, Deltex Medical Group PLC, Masimo Corp, The McEvoy Group, Sramek BioDynamics, OSYPKA MEDICAL |
Other key industry trends
- In terms of revenue, France accounted for 3.9% of the global hemodynamic monitoring devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany hemodynamic monitoring devices market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 177.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hemodynamic Monitoring Devices Market Scope
Hemodynamic Monitoring Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| OSYPKA MEDICAL | View profile | 11-50 | Berlin, Berlin, Germany, Europe | https://www.osypkamed.com |
| Sramek BioDynamics | View profile | 11-50 | Kamuela, Hawaii, United States, North America | https://www.sramekbiodynamics.com |
| The McEvoy Group | View profile | 251-500 | San Francisco, California, United States, North America | https://www.mcevoygroup.com |
| Deltex Medical Group PLC | View profile | 35 | Terminus Road, Chichester, West Sussex, United Kingdom, PO19 8TX | https://www.deltexmedical.com |
| ICU Medical Inc | View profile | 14000 | 951 Calle Amanecer, San Clemente, CA, United States, 92673 | https://www.icumed.com |
| Masimo Corp | View profile | 3796 | 52 Discovery, Irvine, CA, United States, 92618 | https://www.masimo.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
France hemodynamic monitoring devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemodynamic monitoring devices market will help companies and investors design strategic landscapes.
Monitors was the largest segment with a revenue share of 63.78% in 2024. Horizon Databook has segmented the France hemodynamic monitoring devices market based on monitors, disposables covering the revenue growth of each sub-segment from 2021 to 2033.
In 2023, French health agencies estimated the incidence of cancer at 433,136 new cases, with breast cancer (61,214 new cases), prostate cancer (59,885 new cases), and lung cancer (52,777 new cases) being the most prevalent types.
Additionally, a study published in PLOS One in January 2021 reported 2.6 million cases of chronic obstructive pulmonary disease (COPD) in France, projected to reach 2.8 million by 2025. The country's increasing population, coupled with lifestyle and environmental changes, is expected to contribute to the rise of chronic diseases such as cancer, cardiovascular ailments, diabetes, hypertension, and respiratory conditions, driving the demand for hemodynamic monitoring devices to monitor patients' health status regularly.
With approximately 61% of France's population aged between 15 and 64 years, and 21% aged 65 years or older, a substantial demographic segment is susceptible to various health issues. Moreover, government efforts toward digitalization, exemplified by the EUR 650 million (USD 690 million) investment in October 2021 for the national digital health strategy under the Health Innovation 2030 plan, are poised to foster the development of advanced patient monitoring devices.
Reasons to subscribe to France hemodynamic monitoring devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France hemodynamic monitoring devices market databook
-
Our clientele includes a mix of hemodynamic monitoring devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France hemodynamic monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into France hemodynamic monitoring devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
France hemodynamic monitoring devices market size, by product, 2021-2033 (US$M)
France Hemodynamic Monitoring Devices Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
